Cargando…

Urinary Concentration of Monocyte Chemoattractant Protein-1 in Idiopathic Glomerulonephritis: A Long-Term Follow-Up Study

BACKGROUND: Monocyte chemoattractant protein-1 (MCP-1), which is up regulated in kidney diseases, is considered a marker of kidney inflammation. We examined the value of urine MCP-1 in predicting the outcome in idiopathic glomerulonephritis. METHODS: Between 1993 and 2004, 165 patients (68 females)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tofik, Rafid, Ohlsson, Sophie, Bakoush, Omran
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3906252/ https://www.ncbi.nlm.nih.gov/pubmed/24489972 http://dx.doi.org/10.1371/journal.pone.0087857

Ejemplares similares

Monocyte Chemoattractant Protein 1 is a Prognostic Marker in ANCA-Associated Small Vessel Vasculitis
por: Ohlsson, Sophie, et al.
Publicado: (2009)

Increased urinary IgM excretion in patients with chest pain due to coronary artery disease
por: Tofik, Rafid, et al.
Publicado: (2013)

Increased urine IgM excretion predicts cardiovascular events in patients with type 1 diabetes nephropathy
por: Tofik, Rafid, et al.
Publicado: (2009)

Patterns of urinary albumin and IgM associate with markers of vascular ageing in young to middle-aged individuals in the Malmö offspring study
por: Swärd, Per, et al.
Publicado: (2020)

Fractional excretion of IgG in idiopathic membranous nephropathy with nephrotic syndrome: a predictive marker of risk and drug responsiveness
por: Bazzi, Claudio, et al.
Publicado: (2014)

Proteinuria: From Molecular to Clinical Applications in Glomerulonephritis
por: Bazzi, Claudio, et al.
Publicado: (2012)

Urinary Monocyte Chemoattractant Protein-1 in Patients With Alport Syndrome
por: Kashtan, Clifford, et al.
Publicado: (2022)

Characterisation of urinary monocyte chemoattractant protein 1: Potential biomarker for patients with overactive bladder
por: Farhan, Bilal, et al.
Publicado: (2019)

Urinary monocyte chemoattractant protein 1 associated with calcium oxalate crystallization in patients with primary hyperoxaluria
por: Wang, Xiangling, et al.
Publicado: (2020)

Crescentic glomerulonephritis in children: short-term follow-up predicts long-term outcome
por: Zhang, Pei, et al.
Publicado: (2023)

Serum Monocyte Chemoattractant Protein-1 in Pancreatic Cancer
por: Sullivan, Jennifer, et al.
Publicado: (2011)

Role of Monocyte Chemoattractant Protein-1 in Myocardial Infarction
por: Morimoto, Hajime, et al.
Publicado: (2007)

Monocyte Chemoattractant Protein-1 in Antineutrophil Cytoplasmic Autoantibody-Associated Vasculitis: Biomarker Potential and Association with Polymorphisms in the MCP-1 and the CC Chemokine Receptor-2 Gene
por: Jönsson, Nina, et al.
Publicado: (2018)

Serum interferon-γ and urinary monocyte chemoattractant peptide-1 are important factors in the pathogenesis of immunoglobulin A nephropathy
por: Han, Sang Youb, et al.
Publicado: (2021)

Abnormalities in Monocyte Recruitment and Cytokine Expression in Monocyte Chemoattractant Protein 1–deficient Mice
por: Lu, Bao, et al.
Publicado: (1998)

Monocyte chemoattractant protein-1 in patients with peripheral arterial disease.
por: Petrkova, Jana, et al.
Publicado: (2004)

Long-term Low-density Lipoprotein Apheresis in a Patient with Refractory Idiopathic Membranous Glomerulonephritis
por: Yabuuchi, Junko, et al.
Publicado: (2017)

Serum Monocyte Chemoattractant Protein-1 Concentrations Associate With Diabetes Status but Not Arterial Stiffness in Children With Type 1 Diabetes
por: Zineh, Issam, et al.
Publicado: (2009)

Monocyte chemoattractant protein-1 serum levels in ovarian cancer patients
por: Hefler, L, et al.
Publicado: (1999)

Chemoattractant-induced activation of c-fos gene expression in human monocytes
Publicado: (1987)

Influence of HFE variants and cellular iron on monocyte chemoattractant protein-1
por: Mitchell, Ryan M, et al.
Publicado: (2009)

The Potential Role of Monocyte Chemoattractant Protein-1 for Major Depressive Disorder
por: Pae, Chi-Un
Publicado: (2014)

Association between monocyte chemoattractant protein-1 and blood pressure in smokers
por: Komiyama, Maki, et al.
Publicado: (2017)

Ethnic differences in urinary monocyte chemoattractant protein-1 and heparanase-1 levels in individuals with type 2 diabetes: the HELIUS study
por: van der Velden, Anouk I M, et al.
Publicado: (2022)

Sperm chemotaxis is driven by the slope of the chemoattractant concentration field
por: Ramírez-Gómez, Héctor Vicente, et al.
Publicado: (2020)

Association Between Plasma Monocyte Chemoattractant Protein-1 Concentration and Cardiovascular Disease Mortality in Middle-Aged Diabetic and Nondiabetic Individuals
por: Piemonti, Lorenzo, et al.
Publicado: (2009)

Creating a safe bedside teaching environment: a personal experience
por: Bakoush, Omran
Publicado: (2010)

Should we start debating medical ethics in our daily practice?
por: Bakoush, Omran
Publicado: (2007)

LJM Acknowledges its Reviewers
por: Bakoush, Omran
Publicado: (2015)

Purification and amino acid analysis of two human glioma-derived monocyte chemoattractants
Publicado: (1989)

Monocyte chemoattractant protein-1 promoter polymorphism and plasma levels in alzheimer’s disease
por: Porcellini, Elisa, et al.
Publicado: (2013)

Serum monocyte chemoattractant protein-1 is a biomarker in patients with diabetes and periodontitis
por: Radhakrishnan, Preethi, et al.
Publicado: (2014)

Monocyte chemoattractant protein-1: a proinflammatory cytokine elevated in sarcopenic obesity
por: Lim, Jun Pei, et al.
Publicado: (2015)

Monocyte chemoattractant protein-1 is not required for liver regeneration after partial hepatectomy
por: Wyler, Stephanie L., et al.
Publicado: (2016)

CCL2/Monocyte Chemoattractant Protein 1 and Parathyroid Hormone Action on Bone
por: Siddiqui, Jawed Akhtar, et al.
Publicado: (2017)

Cerebrospinal fluid monocyte chemoattractant protein 1 correlates with progression of Parkinson’s disease
por: Santaella, Anna, et al.
Publicado: (2020)

Aqueous humor monocyte chemoattractant protein-1 predicted long-term visual outcome of proliferative diabetic retinopathy undergone intravitreal injection of bevacizumab and vitrectomy
por: Lei, Jianqin, et al.
Publicado: (2021)

Collaboration in long term follow-up of juvenile idiopathic arthritis
por: Larbre, JP, et al.
Publicado: (2008)

Chapter 8: Idiopathic membranoproliferative glomerulonephritis
Publicado: (2012)

Idiopathic or iatrogenic membranous glomerulonephritis? A case of spironolactone-induced membranous glomerulonephritis
por: Inaba, Akimichi, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_lrppv58adj10m7t0r10s9rg9l0